
Cosign AI is an AI-powered platform designed to accelerate clinical trial recruitment. Founded by physicians and AI experts, the company utilizes its 'Retina Intelligence' engine to identify eligible patients in real-time from EHR data, achieving 97.1% accuracy. The platform can screen patients against multiple trial protocols simultaneously, optimizing enrollment and site efficiency. Cosign AI is HIPAA compliant and utilizes Google Cloud and Microsoft Azure for secure data processing. Their solution addresses the significant issue of clinical trial delays, which cost hundreds of thousands of dollars daily. They have demonstrated success across various therapeutic areas, including ophthalmology and pain management.

Cosign AI is an AI-powered platform designed to accelerate clinical trial recruitment. Founded by physicians and AI experts, the company utilizes its 'Retina Intelligence' engine to identify eligible patients in real-time from EHR data, achieving 97.1% accuracy. The platform can screen patients against multiple trial protocols simultaneously, optimizing enrollment and site efficiency. Cosign AI is HIPAA compliant and utilizes Google Cloud and Microsoft Azure for secure data processing. Their solution addresses the significant issue of clinical trial delays, which cost hundreds of thousands of dollars daily. They have demonstrated success across various therapeutic areas, including ophthalmology and pain management.
Core offering: AI platform for real-time clinical trial patient identification and clinician workflow tools
Founding team: Physicians and machine-learning engineers (CEO Will Xie; COO Riya Fukui, MD; CMO Louis Cai, MD)
Performance claims: Cited validations: ~97%+ accuracy and ~2x enrollment improvement
Compliance & infra: HIPAA-compliant; uses Google Cloud and Microsoft Azure for data processing
Clinical trial recruitment and clinician workflow/documentation burden
Healthtech / Clinical trial technology
“Plug and Play (listed as an investor in public profile records)”